Drug Development Executive

Drug Development Executive

Basic/Translational Sciences

CXCR7 : Efficacy of a Novel Agonist and Therapeutic Potential of this Receptor

Vol 1 | June 14, 2025

Eswar Krishnan, MD's avatar
Eswar Krishnan, MD
Jun 13, 2025
∙ Paid

IN THIS ISSUE:

  • Topline Report: CXCR7 Agonist Efficacy in a Rheumatoid Arthritis Model

  • CXCR7 (ACKR3) Biology and Therapeutic Strategies

    • Antagonism

    • Agonism

  • Potential Clinical Development in Rheumatoid Arthritis

  • Disclaimer

User's avatar

Continue reading this post for free, courtesy of Eswar Krishnan, MD.

Or purchase a paid subscription.
© 2026 Eswar Krishnan · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture